India's Pharmaceutical Exports

Country Profile

South Korea

South Korea is a significant market for Indian pharmaceutical exports — $162M in FY 2025–26, with 2.0× growth over the past decade. Medicine Ingredients accounts for 71% of shipments, with vaccines contributing $156K. The compound annual growth rate since FY2015 stands at 6.5%.

🇰🇷 $162M · 2.0× growth since FY2015 · 6.5% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$162M
Exports FY2025–26 DGCIS
2.0×
Growth FY2015→2026
6.5%
CAGR FY2015→2026
71%
Medicine Ingredients Share
5
Product Categories Supplied
South Korea is a significant market for Indian pharmaceutical exports — $162M in FY 2025–26, with 2.0× growth over the past decade. Medicine Ingredients accounts for 71% of shipments, with vaccines contributing $156K. The compound annual growth rate since FY2015 stands at 6.5%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicine Ingredients $114M (70.6%) Medicines $30.5M (18.9%) Surgical & Hospital Supplies $9.16M (5.7%) Traditional & Herbal $7.69M (4.8%) Vaccines $156K (0.1%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to South Korea in the RBI overseas direct investment dataset (2011–2026).